Singapore, April 23 -- The National Reference Laboratory (NRL), part of theM42 Group, is establishing the MENA region's first Center for Advanced Neuro Biochemical Diagnostics dedicated to early detection, in partnership with Neurocode International, global leader of neurology diagnostic solutions, setting a new regional benchmark in the fight against Alzheimer's disease.

Announced on the sidelines ofAbu Dhabi Global Health Week, the Center for Advanced Neuro Biochemical Diagnostics, based in Abu Dhabi, is a pioneering step toward reducing Alzheimer's cases in the UAE and wider region and transforming neurological diagnostics worldwide.

The Center for Advanced Neuro Biochemical Diagnostics aims to revolutionise Alzheimer's diagnosis by ...